Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/32884
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | VERBRUGGE, Frederik | - |
dc.contributor.author | Guazzi, Marco | - |
dc.contributor.author | Testani, Jeffrey M. | - |
dc.contributor.author | Borlaug, Barry A. | - |
dc.date.accessioned | 2020-12-11T11:03:26Z | - |
dc.date.available | 2020-12-11T11:03:26Z | - |
dc.date.issued | 2020 | - |
dc.date.submitted | 2020-11-26T12:50:05Z | - |
dc.identifier.citation | CIRCULATION, 142 (10) , p. 998 -1012 | - |
dc.identifier.issn | 0009-7322 | - |
dc.identifier.uri | http://hdl.handle.net/1942/32884 | - |
dc.description.abstract | Heart failure is characterized by pathologic hemodynamic derangements, including elevated cardiac filling pressures ("backward" failure), which may or may not coexist with reduced cardiac output ("forward" failure). Even when normal during unstressed conditions such as rest, hemodynamics classically become abnormal during stressors such as exercise in patients with heart failure. This has important upstream and downstream effects on multiple organ systems, particularly with respect to the lungs and kidneys. Hemodynamic abnormalities in heart failure are affected by processes that extend well beyond the cardiac myocyte, including important roles for pericardial constraint, ventricular interaction, and altered venous capacity. Hemodynamic perturbations have widespread effects across multiple heart failure phenotypes, ranging from reduced to preserved ejection fraction, acute to chronic disease, and cardiogenic shock to preserved perfusion states. In the lung, hemodynamic derangements lead to the development of abnormalities in ventilatory control and efficiency, pulmonary congestion, capillary stress failure, and eventually pulmonary vascular disease. In the kidney, hemodynamic perturbations lead to sodium and water retention and worsening renal function. Improved understanding of the mechanisms by which altered hemodynamics in heart failure affect the lungs and kidneys is needed in order to design novel strategies to improve clinical outcomes. | - |
dc.description.sponsorship | Dr Verbrugge is supported by a Fellowship of the Belgian American Educational Foundation and by the Special Research Fund of Hasselt University (grant no. BOF19PD04). Dr Borlaug is supported by grants R01 HL128526 and U01 HL125205, both from the US National Heart, Lung, and Blood Institute. | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.subject.other | heart failure | - |
dc.subject.other | hemodynamics | - |
dc.subject.other | kidney | - |
dc.subject.other | lung | - |
dc.title | Altered Hemodynamics and End-Organ Damage in Heart Failure Impact on the Lung and Kidney | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 1012 | - |
dc.identifier.issue | 10 | - |
dc.identifier.spage | 998 | - |
dc.identifier.volume | 142 | - |
local.format.pages | 15 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Borlaug, BA (corresponding author), Mayo Clin & Mayo Fdn, 200 First St SW, Rochester, MN 55905 USA. | - |
dc.description.notes | borlaug.barry@mayo.edu | - |
dc.description.other | Borlaug, BA (corresponding author), Mayo Clin & Mayo Fdn, 200 First St SW, Rochester, MN 55905 USA. borlaug.barry@mayo.edu | - |
local.publisher.place | TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA | - |
local.type.refereed | Refereed | - |
local.type.specified | Editorial Material | - |
dc.identifier.doi | 10.1161/CIRCULATIONAHA.119.045409 | - |
dc.identifier.isi | 000570959700013 | - |
dc.contributor.orcid | Verbrugge, Frederik Hendrik/0000-0003-0599-9290; Borlaug, | - |
dc.contributor.orcid | Barry/0000-0001-9375-0596 | - |
local.provider.type | wosris | - |
local.uhasselt.uhpub | yes | - |
local.description.affiliation | [Verbrugge, Frederik H.; Borlaug, Barry A.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA. | - |
local.description.affiliation | [Verbrugge, Frederik H.] Hasselt Univ, Fac Med & Life Sci, Biomed Res Inst, Hasselt, Belgium. | - |
local.description.affiliation | [Guazzi, Marco] Univ Milan, IRCCS Policlin San Donato, Cardiol Univ Dept, Heart Failure Unit, Milan, Italy. | - |
local.description.affiliation | [Testani, Jeffrey M.] Yale Univ, Sect Cardiovasc Med, New Haven, CT USA. | - |
local.uhasselt.international | yes | - |
item.fullcitation | VERBRUGGE, Frederik; Guazzi, Marco; Testani, Jeffrey M. & Borlaug, Barry A. (2020) Altered Hemodynamics and End-Organ Damage in Heart Failure Impact on the Lung and Kidney. In: CIRCULATION, 142 (10) , p. 998 -1012. | - |
item.validation | ecoom 2022 | - |
item.contributor | VERBRUGGE, Frederik | - |
item.contributor | Guazzi, Marco | - |
item.contributor | Testani, Jeffrey M. | - |
item.contributor | Borlaug, Barry A. | - |
item.fulltext | With Fulltext | - |
item.accessRights | Open Access | - |
crisitem.journal.issn | 0009-7322 | - |
crisitem.journal.eissn | 1524-4539 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
00003017-202009080-00009.pdf | Published version | 2.13 MB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
95
checked on May 8, 2024
Page view(s)
28
checked on Sep 6, 2022
Download(s)
6
checked on Sep 6, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.